Molecular and structural characterization of the SH3 domain of AHI-1 in regulation of cellular resistance of BCR-ABL+chronic myeloid leukemia cells to tyrosine kinase inhibitors-Reference-Cited by-同舟云学术

Molecular and structural characterization of the SH3 domain of AHI-1 in regulation of cellular resistance of BCR-ABL+chronic myeloid leukemia cells to tyrosine kinase inhibitors

Published:2012-07 Issue:13 Volume:12 Page:2094-2106
ISSN:1615-9853
Container-title:PROTEOMICS
language:en
Short-container-title:Proteomics

Author:

Liu Xiaohu¹²,Chen Min¹,Lobo Paolo³,An Jianghong⁴,Grace Cheng S.W.⁴,Moradian Annie⁴,Morin Gregg B.⁴⁵,Van Petegem Filip³,Jiang Xiaoyan¹²⁵

Affiliation:

1. Terry Fox Laboratory; British Columbia Cancer Agency; Vancouver BC Canada

2. Department of Medicine; University of British Columbia; Vancouver BC Canada

3. Department of Biochemistry and Molecular Biology; University of British Columbia; Vancouver BC Canada

4. Michael Smith Genome Sciences Centre; British Columbia Cancer Agency; Vancouver BC Canada

5. Department of Medical Genetics; University of British Columbia; Vancouver BC Canada

Publisher

Wiley

Subject

Molecular Biology,Biochemistry

Reference50 articles.

1. Chronic myeloid leukemia-advances in biology and new approaches to treatment;Goldman;N. Engl. J. Med.,2003

2. The challenges of targeting chronic myeloid leukemia stem cells;Jiang;Clin. Lymphoma Myeloma,2007

3. Molecular mechanisms of transformation by the BCR-ABL oncogene;Sattler;Semin. Hematol.,2003

4. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia;Druker;N. Engl. J. Med.,2001

5. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia;Kantarjian;N. Engl. J. Med.,2002

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HDAC inhibitor suppresses proliferation and tumorigenicity of drug-resistant chronic myeloid leukemia stem cells through regulation of hsa-miR-196a targeting BCR/ABL1;Experimental Cell Research;2018-09

2. PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL + human leukemia;Science Translational Medicine;2018-02-07

3. MS AHI1 genetic risk promotes IFNγ+ CD4+ T cells;Neurology - Neuroimmunology Neuroinflammation;2017-12-12

4. Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma;Journal of Experimental & Clinical Cancer Research;2017-08-16

5. A novel AHI-1–BCR-ABL–DNM2 complex regulates leukemic properties of primitive CML cells through enhanced cellular endocytosis and ROS-mediated autophagy;Leukemia;2017-04-03